Stopping Gout Therapy May Increase Flare Risk, New EULAR Study Finds
New research presented at the annual Congress of the European Alliance of Associations for Rheumatology (EULAR) suggests that continuing urate-lowering therapy (ULT) remains the most effective strategy for maintaining remission in patients with gout, although some patients may successfully remain symptom-free after discontinuing treatment.






















